Cancer Research SABCS Protein Translation and Cancer
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by King, T. J.
Right arrow Articles by Lampe, P. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by King, T. J.
Right arrow Articles by Lampe, P. D.
[Cancer Research 64, 7191-7196, October 15, 2004]
© 2004 American Association for Cancer Research

Advances in Brief

The Gap Junction Protein Connexin32 Is a Mouse Lung Tumor Suppressor

Timothy J. King1,2 and Paul D. Lampe1,2

1 Cancer Prevention Research Program, Public Health Sciences Division, Fred Hutchinson Cancer Research Center, and 2 Department of Pathobiology, University of Washington, Seattle, Washington

Although loss of connexin expression and/or gap junction intercellular communication correlates with decreased growth control and increased neoplastic potential, there is limited evidence directly linking gap junction intercellular communication function with tumor suppression in situ. Here, we show for the first time that a gap junction protein, connexin32 (Cx32), acts as a lung tumor suppressor in a mouse model. Cx32-deficient nontumorous lung tissue exhibited an increased proliferative index (P < 0.001), and, after exposure to the carcinogen diethylnitrosamine, Cx32-deficient mice exhibited a highly statistically significant (P < 0.001) increase in bronchioloalveolar lung tumor incidence (28 of 45, 62%) and a 45% increase in average multiplicity compared with wild-type mice (7 of 29, 24%). Tumors from Cx32-deficient mice also showed increased activation of mitogen-activated protein kinase (P < 0.001) compared with wild-type tumors, implicating this signaling pathway in Cx32/gap junction intercellular communication-associated lung tumorigenesis.




This article has been cited by other articles:


Home page
 Proc. Natl. Acad. Sci. USAHome page
N. Kalcheva, J. Qu, N. Sandeep, L. Garcia, J. Zhang, Z. Wang, P. D. Lampe, S. O. Suadicani, D. C. Spray, and G. I. Fishman
Gap junction remodeling and cardiac arrhythmogenesis in a murine model of oculodentodigital dysplasia
PNAS, December 18, 2007; 104(51): 20512 - 20516.
[Abstract] [Full Text] [PDF]

Home page
 JCBHome page
J. L. Solan, L. Marquez-Rosado, P. L. Sorgen, P. J. Thornton, P. R. Gafken, and P. D. Lampe
Phosphorylation at S365 is a gatekeeper event that changes the structure of Cx43 and prevents down-regulation by PKC
J. Cell Biol., December 17, 2007; 179(6): 1301 - 1309.
[Abstract] [Full Text] [PDF]

Home page
 Exp. Biol. Med.Home page
Y. Hirabayashi, B.-I. Yoon, I. Tsuboi, Y. Huo, Y. Kodama, J. Kanno, T. Ott, J. E. Trosko, and T. Inoue
Protective Role of Connexin 32 in Steady-State Hematopoiesis, Regeneration State, and Leukemogenesis
Experimental Biology and Medicine, May 1, 2007; 232(5): 700 - 712.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Biol. CellHome page
S. Mitra, L. Annamalai, S. Chakraborty, K. Johnson, X.-H. Song, S. K. Batra, and P. P. Mehta
Androgen-regulated Formation and Degradation of Gap Junctions in Androgen-responsive Human Prostate Cancer Cells
Mol. Biol. Cell, December 1, 2006; 17(12): 5400 - 5416.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
E. McLachlan, Q. Shao, H.-l. Wang, S. Langlois, and D. W. Laird
Connexins Act as Tumor Suppressors in Three-dimensional Mammary Cell Organoids by Regulating Differentiation and Angiogenesis.
Cancer Res., October 15, 2006; 66(20): 9886 - 9894.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Sci.Home page
P. D. Lampe, C. D. Cooper, T. J. King, and J. M. Burt
Analysis of Connexin43 phosphorylated at S325, S328 and S330 in normoxic and ischemic heart
J. Cell Sci., August 15, 2006; 119(16): 3435 - 3442.
[Abstract] [Full Text] [PDF]

Home page
 Circ. Res.Home page
J. F. Ek-Vitorin, T. J. King, N. S. Heyman, P. D. Lampe, and J. M. Burt
Selectivity of Connexin 43 Channels Is Regulated Through Protein Kinase C-Dependent Phosphorylation
Circ. Res., June 23, 2006; 98(12): 1498 - 1505.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Q. Shao, H. Wang, E. McLachlan, G. I.L. Veitch, and D. W. Laird
Down-regulation of Cx43 by Retroviral Delivery of Small Interfering RNA Promotes an Aggressive Breast Cancer Cell Phenotype
Cancer Res., April 1, 2005; 65(7): 2705 - 2711.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2004 by the American Association for Cancer Research.